NEW YORK, Nov. 3 (GenomeWeb News) - Lion Bioscience reported a 42-percent year-over-year decline in revenues for its second fiscal quarter today, but the company's bioinformatics business -- which is in the process of being sold to an undisclosed buyer -- posted a profit for the first time in Lion's history.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.